Minasyan Hayk
Independent researcher.
Acute Crit Care. 2022 May;37(2):137-150. doi: 10.4266/acc.2021.01200. Epub 2022 Mar 17.
Patients with sepsis have a wide range of respiratory disorders that can be treated with oxygen therapy. Experimental data in animal sepsis models show that oxygen therapy significantly increases survival, while clinical data on the use of different oxygen therapy protocols are ambiguous. Oxygen therapy, especially hyperbaric oxygenation, in patients with sepsis can aggravate existing oxidative stress and contribute to the development of disseminated intravascular coagulation. The purpose of this article is to compare experimental and clinical data on oxygen therapy in animals and humans, to discuss factors that can influence the results of oxygen therapy for sepsis treatment in humans, and to provide some recommendations for reducing oxidative stress and preventing disseminated intravascular coagulation during oxygen therapy.
脓毒症患者有多种可通过氧疗治疗的呼吸障碍。动物脓毒症模型的实验数据表明,氧疗可显著提高生存率,而关于不同氧疗方案使用的临床数据则不明确。脓毒症患者的氧疗,尤其是高压氧疗,可加重现有的氧化应激并促使弥散性血管内凝血的发生。本文的目的是比较动物和人类氧疗的实验与临床数据,讨论可能影响人类脓毒症治疗氧疗结果的因素,并为在氧疗期间降低氧化应激和预防弥散性血管内凝血提供一些建议。